MBCL-11. TIME TO RADIOTHERAPY IMPACTS SURVIVAL IN PEDIATRIC AND ADOLESCENT NON-METASTATIC MEDULLOBLASTOMA TREATED BY UPFRONT RADIOTHERAPY – A REPORT FROM THE HIT 2000 TRIAL

PURPOSE: To evaluate prognostic factors and impact of participation in a randomized trial in non-metastatic medulloblastoma. METHODS AND PATIENTS: 382 patients with non-metastatic medulloblastoma aged 4–21 years with primary neurosurgical resections between 2001 and 2011 were enrolled into the HIT 2...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Neuro Oncol
मुख्य लेखकों: Dietzsch, Stefan, Placzek, Felix, Pietschmann, Klaus, von Bueren, André O, Matuschek, Christiane, Glück, Albrecht, Guckenberger, Matthias, Budach, Volker, Welzel, Jutta, Pöttgen, Christoph, Schmidberger, Heinz, Heinzelmann, Frank, Paulsen, Frank, Pazos, Montserrat, Schwarz, Rudolf, Hornung, Dagmar, Martini, Carmen, Grosu, Anca Ligia, Meyer, Frank Michael, Jablonska, Karolina, Dunst, Juergen, Kapp, Karin S, Dieckmann, Karin, Timmermann, Beate, Pietsch, Torsten, Warmuth-Metz, Monika, Kwiecien, Robert, Benesch, Martin, Gerber, Nicolas U, Pfister, Stefan M, Clifford, Steven C, von Hoff, Katja, Klagges, Sabine, Rutkowski, Stefan, Kortmann, Rolf-Dieter, Mynarek, Martin
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Oxford University Press 2020
विषय:
Medulloblastoma (Clinical)
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715814/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.487
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन